Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ananth

Showing results (111-120 of 344) with videos related to

Pageof 35
Sort By:
American Journal of Obstetrics and Gynecology|July 10, 2007
Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancySaira Salahuddin, Young Lee, Mary Vadnais, et al.
Hypertension in Pregnancy|January 10, 2017
Relationship between hypoxia and downstream pathogenic pathways in preeclampsiaHenri Augusto Korkes, Leandro De Oliveira, Nelson Sass, et al.
Scientific Reports|September 24, 2017
FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsiaAmi Ashar-Patel, Yasin Kaymaz, Augustine Rajakumar, et al.
Cancer Research|May 8, 1999
Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinomaS Ananth, B Knebelmann, W Grüning, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 8, 2012
Familial factors in the association between preeclampsia and later ESRDBjørn Egil Vikse, Lorentz M Irgens, S Ananth Karumanchi, et al.
Plos One|February 20, 2010
Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal diseaseEliyahu V Khankin, Walter P Mutter, Hector Tamez, et al.
Hypertension in Pregnancy|July 12, 2019
Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsiaAi-Ris Yonekura Collier, Zsuzsanna Zsengeller, Elizabeth Pernicone, et al.
Nature Reviews. Nephrology|October 27, 2009
Angiogenic factor abnormalities and fetal demise in a twin pregnancyMichelle A Hladunewich, Guy Steinberg, S Ananth Karumanchi, et al.
Oncogene|September 20, 2005
Role of elongin-binding domain of von Hippel Lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinomaKaustubh Datta, Susanta Mondal, Sutapa Sinha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 6, 2008
Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysisHui Yi Shan, Sarosh Rana, Franklin H Epstein, et al.
Pageof 35

Showing results (111-120 of 344) with videos related to

Sort By:
Pageof 35
American Journal of Obstetrics and Gynecology|July 10, 2007
Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancySaira Salahuddin, Young Lee, Mary Vadnais, et al.
Hypertension in Pregnancy|January 10, 2017
Relationship between hypoxia and downstream pathogenic pathways in preeclampsiaHenri Augusto Korkes, Leandro De Oliveira, Nelson Sass, et al.
Scientific Reports|September 24, 2017
FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsiaAmi Ashar-Patel, Yasin Kaymaz, Augustine Rajakumar, et al.
Cancer Research|May 8, 1999
Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinomaS Ananth, B Knebelmann, W Grüning, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 8, 2012
Familial factors in the association between preeclampsia and later ESRDBjørn Egil Vikse, Lorentz M Irgens, S Ananth Karumanchi, et al.
Plos One|February 20, 2010
Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal diseaseEliyahu V Khankin, Walter P Mutter, Hector Tamez, et al.
Hypertension in Pregnancy|July 12, 2019
Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsiaAi-Ris Yonekura Collier, Zsuzsanna Zsengeller, Elizabeth Pernicone, et al.
Nature Reviews. Nephrology|October 27, 2009
Angiogenic factor abnormalities and fetal demise in a twin pregnancyMichelle A Hladunewich, Guy Steinberg, S Ananth Karumanchi, et al.
Oncogene|September 20, 2005
Role of elongin-binding domain of von Hippel Lindau gene product on HuR-mediated VPF/VEGF mRNA stability in renal cell carcinomaKaustubh Datta, Susanta Mondal, Sutapa Sinha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 6, 2008
Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysisHui Yi Shan, Sarosh Rana, Franklin H Epstein, et al.
Pageof 35